On May 1, 2026, an absorption-type company split and absorption-type merger will be conducted between consolidated subsidiaries to mutually succeed part of the pharmacy business, and Sakura Pharmacy Co., Ltd. will be absorbed by Kraft Co., Ltd.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9627","jir_company_name":"AIN HOLDINGS INC.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-02-27","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/9627-20260227-01.pdf","jir_short_summary":"On May 1, 2026, an absorption-type company split and absorption-type merger will be conducted between consolidated subsidiaries to mutually succeed part of the pharmacy business, and Sakura Pharmacy Co., Ltd. will be absorbed by Kraft Co., Ltd.","jir_summary":"### Overview of Group Restructuring\nAIN HOLDINGS INC. will execute an absorption-type company split and absorption-type merger between consolidated subsidiaries effective May 1, 2026. Specifically, Ain Pharmacies will transfer part of its pharmacy operations in the Chugoku region to Pharmacy, and Pharmacy will transfer part of its pharmacy operations in the Kansai and Shikoku regions to Ain Pharmacies in a reciprocal absorption-type company split. Additionally, Sakura Pharmacy Co., Ltd. will be dissolved through an absorption-type merger with Kraft Co., Ltd. as the surviving company. These restructurings are conducted among wholly owned subsidiaries and involve no allocation of shares or provision of consideration.\n\n### Purpose of Restructuring and Future Outlook\nThis intra-group restructuring aims to improve operational efficiency of pharmacy management and reduce redundant administrative tasks, thereby enhancing the overall business efficiency of the group. Since the restructuring is among wholly owned subsidiaries, the impact on financial results is expected to be minimal. Changes in representatives are planned for some subsidiaries, and there will be no changes to company name, business content, capital, or fiscal year-end after the restructuring.","jir_financial_highlights":"Absorption-type Company Split \u2460 Net Sales (Divided Business Segment): 10,426 million yen (Unknown)\nAbsorption-type Company Split \u2461 Net Sales (Divided Business Segment): 5,500 million yen (Unknown)\nSakura Pharmacy Net Sales: 35,082 million yen (Unknown)\nKraft Net Sales: 110,168 million yen (Unknown)","jir_category":"","jir_hashtags":"#AINHOLDINGSINC, #CorporateRestructuring, #AbsorptionTypeCompanySplitBetweenConsolidatedSubsidiaries, #AbsorptionTypeMergerBetweenConsolidatedSubsidiaries, #JapaneseStocks","jir_key_figures":"Absorption-type Company Split \u2460 Net Sales (Divided Business Segment): 10,426 million yen\nAbsorption-type Company Split \u2461 Net Sales (Divided Business Segment): 5,500 million yen\nSakura Pharmacy Net Sales: 35,082 million yen","jir_meta_title":"AIN HOLDINGS INC. to Conduct Group Restructuring as of May 1, 2026 - Absorption-type Company Split and Merger Between Consolidated Subsidiaries","jir_meta_description":"AIN HOLDINGS INC. will execute absorption-type company splits and mergers between consolidated subsidiaries on May 1, 2026, aiming to enhance efficiency in its pharmacy business. Net sales of 10,426 million yen and 5,500 million yen from the divided business segments are expected to be succeeded.","jir_og_title":"AIN HOLDINGS Announces Group Restructuring","jir_og_description":"Effective May 1, 2026, absorption-type company splits and mergers between consolidated subsidiaries will be conducted to improve business efficiency.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8852,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"corporate_restructuring","footnotes":""},"sector":[],"importance":[],"class_list":["post-31978","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n